newsfilter
← Latest News
ACCESS Newswire·

Edesa Biotech to Participate in Upcoming Investor Conferences

TORONTO, ON / ACCESSWIRE / April 2, 2024 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today